NCT02917226

Brief Summary

The purpose of the study is to develop a user-friendly, comprehensive, fully integrated web and mobile-based Clinical Decision Support and Monitoring System (CDSMS) for DM diseases screening, diagnosis, treatment and monitoring for the use of physicians and patients in primary care and to determine the effectiveness of the system. For validating the CDSMS for diabetes patients, randomized controlled trial will be conducted.A parallel single blind randomized controlled trial will be implemented. 10 physicians and their 439 patients are involved in the study. According to the results of screening which is done using developed CDSMS, DM diagnosed patients will be recruited for trial from the primary care centers by the physicians. The recruited patients will register to the CDSMS with their accounts given by their physicians. Eligible participants will be assigned to intervention and control groups with simple randomization. The significance level will be accepted as p\<0,05. In the intervention group, the system recommendations on diagnosis, treatment and monitoring will be carried out as the final decision given by the physician. In the control group, physicians will treat DM patients as the general routine. Patients in both groups will be monitored for 6 months. Patient data on 0th and 6th month will be compared. Clinical and laboratory outcomes will be face-to-face assessed, others will be online self-assessed.

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 28, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Last Updated

September 29, 2016

Status Verified

September 1, 2016

First QC Date

August 24, 2016

Last Update Submit

September 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • fasting blood glucose

    Change from baseline fasting blood glucose at 6 months

Study Arms (2)

Clinical decision support and monitoring system

EXPERIMENTAL
Other: Clinical decision support and monitoring system

Control Group

NO INTERVENTION

Interventions

Clinical decision support and monitoring system

Eligibility Criteria

Age40 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over age 40
  • Volunteer
  • Computer and Internet literacy
  • DM diagnosed or having at least one of diagnostic criteria.
  • These criteria;
  • HbA1c ≥ 6.5
  • FPG ≥ 126 mg / dl
  • hour postprandial glucose ≥ 200 mg / dl
  • Any time postprandial glucose ≥ 200 mg / dl
  • Diabetes symptoms

You may not qualify if:

  • Having a communication problem
  • Type 1 diabetes
  • MODY type DM
  • Level of psychiatric disorders in psychosis
  • Dementia ones

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kart O, Mevsim V, Kut A, Yurek I, Altin AO, Yilmaz O. A mobile and web-based clinical decision support and monitoring system for diabetes mellitus patients in primary care: a study protocol for a randomized controlled trial. BMC Med Inform Decis Mak. 2017 Nov 29;17(1):154. doi: 10.1186/s12911-017-0558-6.

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Vildan Mevsim, Prof., PhD, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr. Vildan MEVSİM, MD, PhD

Study Record Dates

First Submitted

August 24, 2016

First Posted

September 28, 2016

Primary Completion

December 1, 2017

Last Updated

September 29, 2016

Record last verified: 2016-09